Tandem Diabetes Care, Inc. Stock
Equities
TNDM
US8753722037
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43 USD | -5.14% | -11.34% | +45.37% |
Financials (USD)
Sales 2024 * | 869M | Sales 2025 * | 961M | Capitalization | 2.78B |
---|---|---|---|---|---|
Net income 2024 * | -110M | Net income 2025 * | -74M | EV / Sales 2024 * | 3.1 x |
Net cash position 2024 * | 88.94M | Net cash position 2025 * | 48.12M | EV / Sales 2025 * | 2.84 x |
P/E ratio 2024 * |
-26
x | P/E ratio 2025 * |
-38.6
x | Employees | 2,400 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.23% |
Latest transcript on Tandem Diabetes Care, Inc.
1 day | -5.14% | ||
1 week | -11.34% | ||
Current month | -16.06% | ||
1 month | -9.09% | ||
3 months | +50.24% | ||
6 months | +50.19% | ||
Current year | +45.37% |
Managers | Title | Age | Since |
---|---|---|---|
John Sheridan
CEO | Chief Executive Officer | 68 | 13-02-28 |
Leigh Vosseller
DFI | Director of Finance/CFO | 51 | 13-08-31 |
Shannon Hansen
CMP | Compliance Officer | 58 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 19-01-02 | |
Director/Board Member | 64 | 13-06-30 | |
John Sheridan
CEO | Chief Executive Officer | 68 | 13-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.45% | 2 M€ | +9.20% | ||
0.32% | 415 M€ | -.--% | ||
0.10% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-17 | 43 | -5.14% | 1,041,170 |
24-06-14 | 45.33 | -0.26% | 1,107,226 |
24-06-13 | 45.45 | -4.01% | 1,342,586 |
24-06-12 | 47.35 | -2.15% | 799,673 |
24-06-11 | 48.39 | -0.23% | 1,053,599 |
Delayed Quote Nasdaq, June 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.37% | 2.78B | |
-6.01% | 180B | |
-2.95% | 105B | |
-4.54% | 67.27B | |
-6.09% | 46.34B | |
+14.28% | 46.22B | |
+4.14% | 40.1B | |
+19.36% | 30.92B | |
+12.05% | 24.22B | |
-4.56% | 24.48B |
- Stock Market
- Equities
- TNDM Stock